用户名:  密码:   
网站首页即时通讯活动公告最新消息科技前沿学人动向两岸三地人在海外历届活动关于我们联系我们申请加入
栏目导航 — 美国华裔教授专家网最新消息社区报道
关键字  范围   
 
The FDA has recently approved the following devices to be marketed.
2024/10/13 20:33:36 | 浏览:1175 | 评论:0

The FDA has recently approved the following devices to be marketed.

Occlutech ASD Occluder and Occlutech Pistol Pusher – P200032

The Occlutech ASD Occluder is a permanent implant intended to treat an atrial septal defect (ASD). The device has two umbrella-shaped flexible discs with a connection in the middle. When the device is carefully positioned in the ASD, the two discs cover both sides of the atrial septum, closing the hole. After a few months, the device will be covered by a thin layer of tissue.

The FDA has recently approved the following devices to be marketed.

TZ Medical Adult and Pediatric Multi-Function Defibrillation Electrodes and Adaptors – P200005

TZ Medical Multi-Function Defibrillation Electrodes and Adaptors monitor the heart’s rhythm and deliver a pacing or electrical shock from a defibrillator(a device that applies an electric charge to the heart to restore a normal heartbeat)to a person with an arrhythmia.

The FDA has recently approved the following devices to be marketed.


Edwards EVOQUE Tricuspid Valve Replacement System – P230013

The Edwards EVOQUE Tricuspid Valve Replacement System mainly includes an artificial tricuspid valve(called the EVOQUE valve)and a delivery catheter. The EVOQUE valve is made of cow tissue attached to a self-expanding metal(nickel-titanium)frame for support. It can be used to replace the tricuspid valve of the heart without open-heart surgery. The tricuspid valve prevents backflow of blood into the right atrium(upper right chamber of the heart)from the right ventricle(lower right chamber of the heart).

The FDA has recently approved the following devices to be marketed.

Spectra WaveWriter, WaveWriter Alpha, WaveWriter Alpha Prime Spinal Cord Stimulation Systems - P030017/S363

Boston Scientific’s WaveWriter Spinal Cord Stimulation(SCS)Systems are implanted(placed into the body)to help reduce pain that is chronic(long-term)and intractable(difficult to manage)in the legs, arms, or trunk. This supplement expands the Indications for Use to include treatment of low back and leg pain that is difficult to manage without prior back surgery.

The FDA has recently approved the following devices to be marketed.

XACT Carotid Stent System – P040038/S043

The XACT Carotid Stent System is intended to be used to reopen narrowed parts of the carotid arteries in the neck that supply blood to the brain. The system consists of a delivery catheter and a self-expanding metal stent made of nitinol.
This approval expands the indications for the XACT Carotid Stent System to be used during a Transcarotid Artery Revascularization(TCAR)procedure, in which a device is placed in the neck instead of in the thigh in combination with the ENROUTE Transcarotid Neuroprotection System(ENROUTE NPS). The ENROUTE NPS temporarily reverses blood flow at the treatment area to redirect pieces that may become loose during the procedure from potentially traveling to the brain.

The FDA has recently approved the following devices to be marketed.

Xstim Spine Fusion Stimulator – P230025

The Xstim Spine Fusion Stimulator is a bone growth stimulator(BGS)device intended be used on the lower back. The device components include a controller for creating signals, a belt clip, a rechargeable lithium-ion battery pack and charging unit, controller cables, hydrogel electrode pads that stick to the skin, optional electrode covers, including some for use only when showering, and a carry case.

The FDA has recently approved the following devices to be marketed.

INTELLANAV STABLEPOINT™ Ablation Catheter & Force Sensing System on the RHYTHMIA HDX™ Mapping System - P150005/S074

The INTELLANAV STABLEPOINT Ablation Catheter uses radiofrequency(RF)energy applied by the catheter tip to destroy heart tissue cells that are causing heart rhythm problems(arrhythmias).

The FDA has recently approved the following devices to be marketed.

 

Vercise PC, Vercise Gevia, and Vercise Genus Deep Brain Stimulation Systems – P150031/S064

The Vercise PC, Vercise Gevia, and Vercise Genus Deep Brain Stimulation(DBS)Systems are implantable devices that deliver low-intensity electrical pulses to nerve centers in the brain. This supplement expands the Indications for Use to include an option of two-sided stimulation for people who are diagnosed with essential tremor not adequately controlled by medication and where the tremor creates a significant inability to function.

The FDA has recently approved the following devices to be marketed.

AGENT Paclitaxel-Coated Balloon Catheter – P230035

The AGENT Paclitaxel-Coated Balloon Catheter(Agent DCB)uses a narrow tube with a balloon on the end to reopen arteries that supply blood to the heart and are blocked or narrowed due to coronary artery disease(CAD). The balloon is coated on its outer surface with the drug paclitaxel, which may help prevent the arteries from narrowing again(restenosis).

The FDA has recently approved the following devices to be marketed.

LIAISON Biotrin Parvovirus B19 IgG Plus, LIAISON Biotrin Control Parvovirus B19 IgG Plus – P220034

The LIAISON Biotrin Parvovirus B19 IgG Plus is a laboratory test used to detect human parvovirus IgG antibodies against the parvovirus B19 antigen in the blood.

The FDA has recently approved the following devices to be marketed.

 

TriClip G4 System – P230007

The TriClip G4 System is used to treat tricuspid regurgitation(leaky tricuspid valve)often caused by an enlarged heart or damaged tricuspid valve leaflets, without open-heart surgery.

The FDA has recently approved the following devices to be marketed.

ColoSense – P230001

ColoSense is a laboratory test that measures ribonucleic acid(RNA)and hemoglobin(blood)in human stool that is not visible to the eye(fecal occult blood), which may indicate the presence of colorectal cancer or of advanced adenomas(growths on the lining of the colon or rectum). The ColoSense Collection Kit consists of a container for collection of stool and a separate sampler for collection of stool for hemoglobin testing(only one stool is required to obtain both samples). Both samples are required to obtain a ColoSense result. Additionally, bowel prep or following dietary or medication restrictions to complete the test is not necessary.


相关栏目:『社区报道
谁做下一任美联储主席,摩根大通CEO戴蒙押注沃什,而非哈赛特 2025-12-16 [27]
FBI向全美华人发出最高级别警告! 2025-12-16 [65]
离了大谱,斯坦福学生四成是残疾人 2025-12-09 [133]
美国2025年《国家安全战略》全文(译文+原文) 2025-12-09 [918]
国际学生大逃离 加州痛失1.6亿美元跌幅全美第一 2025-12-07 [162]
15岁量子物理博士横空出世 全球科技巨头争抢 2025-12-07 [214]
戴尔夫妇捐62.5亿美元 为2500万美国儿童开设投资账户 2025-12-07 [174]
在美华人就医指南 理解体系篇: 在美国,穷人真的“去急诊就行了”?拆解美国医疗的底层源代码 2025-12-07 [205]
欧洲豪赌钻石芯片 2025-12-07 [170]
太离谱了!新泽西水疗中心因拒绝男人进入女浴室被告上法庭 2025-11-30 [369]
相关栏目更多文章
最新图文:
:美国加大审查范围 北大多名美国留学生遭联邦调查局质询 :天安门广场喜迎“十一”花团锦簇的美丽景象 马亮:做院长就能够发更多论文?论文发表是不是一场“权力的游戏”? :印裔人才在美碾压华裔:我们可以从印度教育中学到什么? :北京452万人将从北京迁至雄安(附部分央企名单) :《2019全球肿瘤趋势报告》 :阿尔茨海默病预防与干预核心讯息图解 :引力波天文台或有助搜寻暗物质粒子
更多最新图文
更多《即时通讯》>>
 
打印本文章
 
您的名字:
电子邮件:
留言内容:
注意: 留言内容不要超过4000字,否则会被截断。
未 审 核:  是
  
关于我们联系我们申请加入后台管理设为主页加入收藏
美国华裔教授专家网版权所有,谢绝拷贝。如欲选登或发表,请与美国华裔教授专家网联系。
Copyright © 2025 ScholarsUpdate.com. All Rights Reserved.